PubMed Health⌕ Search

Biomedical subjects

A F Shernoff

Publications and source records attributed to A F Shernoff.

9 recordsLinked to original sources
PubMed1994

Implants for type II diabetic patients: interim report. VA Implants in Diabetes Study Group.

One hundred seventy-eight implants from three systems were placed in 89 type II diabetic patients at 13 Department of Veterans Affairs medical centers. Four failures (2.2 percent) were found at uncovering. The failure rate increased to 7.3 percent at the end of 1 year (nine additional failures). Study patients will be monitored for an additional 4 years. Initial results suggest that type II diabetic patients can be considered for dental implant therapy.

Dental Care for Chronically Ill↗
PubMed1991

Osseointegrated implants with an intramobile element in the treatment of edentulous jaws.

Edentulous patients have demonstrated impaired masticatory ability with conventional dentures. The masticatory deficiency is due, in part, to the instability of the mandibular denture and the lack of proprioception of conventional dentures. The Interpore IMZ implant offers an intramobile element in the design that may enhance proprioception of screw-retained dentures. The following case reports evaluated the stability and patient response of 10 edentulous patients who received a screw-retained denture with the intramobile element. The results indicated that the IMZ system can be successfully incorporated in this design.

Dental Implantation, Endosseous↗
PubMed1989

An improved technique for bite mark impressions.

This article demonstrates a technique for making a custom tray over a bite mark and making an accurate impression of the mark. This technique is cleaner and easier than previously published methods, and causes no undue thermal trauma to living patients.

Bites and Stings↗
PubMed1986

Using soft vinyl stents to facilitate augmentation of maxillary anterior atrophic ridges with hydroxyapatite.

A technique has been described for fabrication of a surgical template made of soft vinyl mouthguard material. Use of this stent at the time of surgery can be of great value to the oral surgeon and the prosthodontist. The risk of excessive augmentation and migration of the particulate hydroxyapatite to an undesired area will be minimized if the stent is used as a matrix. Uniform results in size and form of the ridge can be obtained from the surgical procedure when the stent is used. The denture-bearing area of the maxillary anterior ridge will improve significantly, enabling the dentist to make a maxillary complete denture.

Alveolar Ridge Augmentation↗
PubMed1984

An alternative to conventional overdenture attachments with Molloplast-B: a technique.

The use of Molloplast-B within the abutments of mandibular overdentures is an easy and inexpensive method for increasing retention and stability of dentures. The use of a retentive area prepared in natural tooth structure increases retentive capabilities for the overdenture patient. Unlike some silicone denture liners, Molloplast-B has shown an inhibitory effect to the growth of Candida albicans. Molloplast-B can be used in the conventional overdenture method or as described for an immediate overdenture. This type of overdenture can be relined easily to adjust for changes in mouth architecture. How well this material will retain its shape and consistency needs to be observed.

Dental Abutments↗
PubMedDate not supplied

Dental endosseous implant assessments in a type 2 diabetic population: a prospective study.

Diabetes mellitus, a prevalent disorder worldwide, is associated with systemic adverse sequelae, such as wound healing alterations, which may affect osseointegration of dental implants. This prospective multicenter study assessed the success of 2-stage endosseous root-form implants (3 different implant systems) placed in the mandibular symphysis of 89 male type 2 diabetic subjects. The implants were uncovered approximately 4 months after placement, restored with an implant-supported, Hader bar clip-retained overdenture, and maintained at scheduled follow-up data collection examinations for 60 months after loading. Sixteen (9.0%) of the 178 implants failed. Life table methods calculated implant survival at approximately 88%, from prosthesis placement through the 60-month follow-up, and at approximately 90% from implant placement through the observation period. No implants failed between surgical placement and uncovering, 5 failed at uncovering, 7 failed after uncovering before prosthesis placement, and 4 failed after prosthesis placement. Fasting plasma glucose (FPG) and glycosylated hemoglobin (HbA1c) values were determined before implant placement (baseline) and approximately 4 months later at surgical uncovering (follow-up). The 5-year implant outcomes (successes versus failures) were analyzed against the following predictor variables: (1) baseline and follow-up FPG values, (2) baseline and follow-up HbA1c values, (3) subject age, (4) duration of diabetes (years), (5) baseline diabetic therapy, (6) smoking history, and (7) implant length. Regression analysis found only duration of diabetes (P < .025) and implant length (P < .001) to be statistically significant predictors of implant failure. There was no statistically significant difference in failure rates between the 3 different implant systems used. This study supports the use of dental implants in type 2 diabetic patients.

Adult↗